RE:RE:RE:RE:As predicted. shorting awayI was asked why I suppport mangement?
First and formost, mangment of any company can not control the shareprice.
Next , they have recently aquired admitance to a world renowned Pancreatic cancer study.
Supported by many outside agancies.
The problem is that of time & failed events so far.
Like I said, many want instant results.
Pointing agai to the Mbc overall survival O.S.
That number is basd on real peoples lives that have been extended. Lengthing the outcome of a very long trial.
hard concept for some to grasp...the longer the MBc O.S. takes, the better.
Funny, mangement puts out promotional material & the FUDSTERS complain.
The same folks who claim there is no suppport from mangement for the company?
Biotechs are very risky, very , very risky.
One hand ? ONC has survived 20+ years. many have come & gone.
Dillution? I have yet to hear anyone come up with an alternative?
Thy need to keep the doors open & the trials going to get approval.
The recent CGAR endorcement is awsome news.
Stay tuned, the business side will follow.
ONC "mangement" knew full well the CGAR opportunity was arrivinig. Why sell out,, before fully matured.
My coments are certianly well above the head of most who are only lookng for blame
Yes thre is little volume.
Flying unde the radar.
soon to be discovered.